Kyung Koo Kang

533 total citations
32 papers, 464 citations indexed

About

Kyung Koo Kang is a scholar working on Psychiatry and Mental health, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Kyung Koo Kang has authored 32 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Psychiatry and Mental health, 12 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Molecular Biology. Recurrent topics in Kyung Koo Kang's work include Sexual function and dysfunction studies (14 papers), Hormonal and reproductive studies (11 papers) and Urinary Bladder and Prostate Research (6 papers). Kyung Koo Kang is often cited by papers focused on Sexual function and dysfunction studies (14 papers), Hormonal and reproductive studies (11 papers) and Urinary Bladder and Prostate Research (6 papers). Kyung Koo Kang collaborates with scholars based in South Korea and Australia. Kyung Koo Kang's co-authors include Byoung Ok Ahn, Moohi Yoo, Seul Min Choi, Won Bae Kim, Jong Won Kwon, Min Jung Lee, Tae Young Oh, Sukhyang Lee, Sung Keun Kang and Soon Hoe Kim and has published in prestigious journals such as The Journal of Urology, European Urology and Life Sciences.

In The Last Decade

Kyung Koo Kang

30 papers receiving 443 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kyung Koo Kang South Korea 13 172 143 110 76 70 32 464
Soon Hoe Kim South Korea 12 108 0.6× 135 0.9× 107 1.0× 44 0.6× 12 0.2× 18 385
Penghui Yuan China 11 86 0.5× 102 0.7× 154 1.4× 102 1.3× 13 0.2× 28 432
Yue-Hua Huang China 6 262 1.5× 181 1.3× 125 1.1× 125 1.6× 21 0.3× 12 531
Zhe Meng China 12 31 0.2× 51 0.4× 216 2.0× 106 1.4× 7 0.1× 24 635
Gerrit Voortman Netherlands 16 106 0.6× 82 0.6× 106 1.0× 7 0.1× 179 2.6× 26 695
Monika Dvořáková Slovakia 15 111 0.6× 41 0.3× 180 1.6× 5 0.1× 37 0.5× 34 608
Claudia Baraldi Italy 13 48 0.3× 29 0.2× 98 0.9× 9 0.1× 21 0.3× 22 378
Walidah Walker United States 8 24 0.1× 177 1.2× 145 1.3× 31 0.4× 618 8.8× 9 1.2k
Sarah Rogers United States 11 47 0.3× 13 0.1× 86 0.8× 11 0.1× 26 0.4× 25 659
Olga M. Calof United States 5 83 0.5× 674 4.7× 290 2.6× 15 0.2× 18 0.3× 7 885

Countries citing papers authored by Kyung Koo Kang

Since Specialization
Citations

This map shows the geographic impact of Kyung Koo Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyung Koo Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyung Koo Kang more than expected).

Fields of papers citing papers by Kyung Koo Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyung Koo Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyung Koo Kang. The network helps show where Kyung Koo Kang may publish in the future.

Co-authorship network of co-authors of Kyung Koo Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Kyung Koo Kang. A scholar is included among the top collaborators of Kyung Koo Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyung Koo Kang. Kyung Koo Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Jong‐Hwa, Dae Young Lee, Kyung Koo Kang, et al.. (2020). Gender differences and dose proportionality in the toxicokinetics of udenafil and its active metabolite following oral administration in rodents. Toxicology and Applied Pharmacology. 410. 115339–115339. 1 indexed citations
2.
Kang, Kyung Koo, et al.. (2013). Ejaculatory Responses are Inhibited by a New Chemical Entity, DA-8031, in Preclinical Rodent Models of Ejaculation. Urology. 81(4). 920.e13–920.e18. 20 indexed citations
3.
Choi, Seul Min, et al.. (2011). Effects of DA-6034, a Flavonoid Derivative, on Mucin-like Glycoprotein and Ocular Surface Integrity in a Rabbit Model. Arzneimittelforschung. 59(10). 498–503. 8 indexed citations
4.
Choi, Seul Min, et al.. (2009). Effects of DA-6034 on Aqueous Tear Fluid Secretion and Conjunctival Goblet Cell Proliferation. Journal of Ocular Pharmacology and Therapeutics. 25(3). 209–214. 10 indexed citations
5.
Choi, Seul Min, et al.. (2009). Beneficial effects of the combination of amlodipine and losartan for lowering blood pressure in spontaneously hypertensive rats. Archives of Pharmacal Research. 32(3). 353–358. 10 indexed citations
6.
Park, Jong Kwan, et al.. (2008). Why a combined intracavernosal injection with trimix and oral sildenafil is reliable therapy in the ultrasonographic evaluation of erectile dysfunction. British Journal of Urology. 102(8). 993–997. 7 indexed citations
7.
8.
Choi, Seul Min, et al.. (2007). Gastroprotective Effects of DA-6034, a New Flavonoid Derivative, in Various Gastric Mucosal Damage Models. Digestive Diseases and Sciences. 52(11). 3075–3080. 43 indexed citations
9.
Lee, Seung‐Ho, et al.. (2006). Inhibitory Effect of DA-9201, an Extract of Oryza sativa L., on Airway Inflammation and Bronchial Hyperresponsiveness in Mouse Asthma Model. Biological and Pharmaceutical Bulletin. 29(6). 1148–1153. 6 indexed citations
10.
Choi, Seul Min, Kyung Koo Kang, Byoung Ok Ahn, et al.. (2005). Chronic administration of phosphodiesterase 5 inhibitor improves erectile and endothelial function in a rat model of diabetes. International Journal of Andrology. 28(5). 260–266. 32 indexed citations
11.
Choi, Seul Min, et al.. (2005). DA-9201 shows anti-asthmatic effects by suppressing NF-кB expression in an ovalbumin-lnduced mouse model of asthma. Archives of Pharmacal Research. 28(12). 1350–1357. 4 indexed citations
12.
Kang, Kyung Koo, et al.. (2004). The effect of DA-8159 on corpus cavernosal smooth muscle relaxation and penile erection in diabetic rabbits. Urological Research. 32(2). 107–111. 20 indexed citations
13.
Kang, Kyung Koo, et al.. (2004). DA-8159 has erectile potentials much longer than the plasma half-life in a conscious rabbit model. Life Sciences. 75(9). 1075–1083. 8 indexed citations
14.
Shim, Hyun Joo, Dong Kim, Kyung Koo Kang, et al.. (2003). Subacute toxicities and toxicokinetics of DA‐8159, a new phosphodiesterase type V inhibitor, after single and 4‐Week repeated oral administration in rats. Biopharmaceutics & Drug Disposition. 24(9). 409–418. 8 indexed citations
15.
Kang, Kyung Koo, et al.. (2003). DA-8159, a potent cGMP phosphodiesterase inhibitor, attenuates monocrotaline-induced pulmonary hypertension in rats. Archives of Pharmacal Research. 26(8). 612–619. 8 indexed citations
16.
Kang, Kyung Koo, et al.. (2003). DA-8159, a new PDE5 Inhibitor, Induces Penile Erection in Conscious and Acute Spinal Cord Injured Rabbits. European Urology. 43(6). 689–695. 26 indexed citations
17.
Kang, Kyung Koo, Seul Min Choi, Jae‐Hoon Choi, et al.. (2003). Safety Evaluation of GX-12, a New HIV Therapeutic Vaccine: Investigation of Integration into the Host Genome and Expression in the Reproductive Organs. Intervirology. 46(5). 270–276. 21 indexed citations
18.
Oh, Tae Young, Kyung Koo Kang, Byoung Ok Ahn, Moohi Yoo, & Won Bae Kim. (2000). Erectogenic effect of the selective phosphodiesterase type 5 inhibitor, DA-8159. Archives of Pharmacal Research. 23(5). 471–476. 38 indexed citations
19.
Kim, Dong Hwan, et al.. (1999). Acute Toxicity Study on Recombinant Human Basic Fibroblast Growth Factor in Rats and Dogs. Toxicological Research. 15(2). 211–214. 1 indexed citations
20.
Ahn, Byoung Ok, et al.. (1999). Four-week Repeated Dose Toxicity Study of Recombinant Human Basic Fibroblast Growth Factor by Subcutaneous Administration in Rats. Toxicological Research. 15(2). 215–226. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Soon Hoe Kim Breakdown of academic impact, for papers by Penghui Yuan Breakdown of academic impact, for papers by Yue-Hua Huang Breakdown of academic impact, for papers by Zhe Meng Breakdown of academic impact, for papers by Gerrit Voortman Breakdown of academic impact, for papers by Monika Dvořáková Breakdown of academic impact, for papers by Claudia Baraldi Breakdown of academic impact, for papers by Walidah Walker Breakdown of academic impact, for papers by Sarah Rogers Breakdown of academic impact, for papers by Olga M. Calof
Rankless by CCL
2026